Hua Medicine HKEX IPO

14/9/2018
IPO

Announced

14/9/2018


Overview:

  • Hua Medicine aims to raise up to $400 million with its IPO in Hong Kong.

Daniel Semerdzhiev - Data analyst

Jurisdiction:

Hong Kong SAR

Deal type:

IPO

Practice area:

Capital markets : Equity

Governing law:

Hong Kong

Industry sector:

Healthcare


Firms:

Party: Goldman Sachs (Underwriter)

Party: CLSA (Underwriter)

Party: Guotai Junan Securities (Hong Kong) (Underwriter)


Party: Hua Medicine (Issuer)

Lawyer: Derrick Kan


Party: Goldman Sachs (Underwriter)

Party: CLSA (Underwriter)

Party: Guotai Junan Securities (Hong Kong) (Underwriter)